Medical News

RSS

Arno Therapeutics closes private placement to advance cancer treatment

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced that it has closed a private placement of its securities resulting in gross proceeds to the company of over $15 million.

14 Sep 2010

Study finds new therapeutic target for polycystic kidney disease

In work suggesting a new approach to treating polycystic kidney disease (PKD), a leading cause of kidney failure, researchers at Children's Hospital Boston were able to block the formation of fluid-filled cysts, the hallmark of the disease, in a mouse model. Their findings, using a compound that inhibits a receptor known as c-Met, will be published in the September 13th online edition of the Journal of Clinical Investigation.

14 Sep 2010

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from the first of two Phase 3 clinical trials assessing the efficacy and safety of the investigational drug, linaclotide, in patients with irritable bowel syndrome with constipation (IBS-C).

14 Sep 2010

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

14 Sep 2010

Arthritis Foundation, Takeda launch Gout Living educational campaign

The Arthritis Foundation and Takeda Pharmaceuticals North America, Inc., announced the launch of a new educational campaign, Gout Living, to help increase understanding and encourage better management of gout.

14 Sep 2010

Advantec announces partnership with Teladoc for telehealth consultations

Advantec, an innovative provider of HR, Payroll and Benefits services to small and mid-sized businesses, announced today a new partnership with Teladoc, the nation's leading provider of telehealth medical consultations.

14 Sep 2010

Pharmacyclics reports $9.3 million increase in total revenue for 2010 fiscal year

Pharmacyclics, Inc. today reported financial results for its fiscal year and fourth quarter which ended June 30, 2010.

14 Sep 2010

Queensland health staff threaten to strike

According to a union some Queensland Health professionals are ready to strike over a government wage offer. The Liquor, Hospitality and Miscellaneous Workers Union (LHMWU) and Queensland Public Sector Union (QPSU) (that includes radiographers, scientists and pharmacists) started this campaign across Queensland on Monday. They are protesting even on radio and print ads for a 2.5 per cent rise a year, over three years.

13 Sep 2010

Complementary medicine to save millions: Report

According to a new report substituting pharmaceutical antidepressants with St John’s Wort could save the health system $50 million a year. This research was conducted by Access Economics for the National Institute of Complementary Medicine (NICM) at the University of Western Sydney. It showed that cost effectiveness of complementary and alternative therapies have the potential to cut costs without compromising patient outcomes.

13 Sep 2010

Myopia and Glaucoma genes identified

In global studies of more than 40,000 people from countries around the world, including Australia, researchers have found the genes responsible for two of the most common eye disorders - short-sightedness or myopia and glaucoma. The scientists believe this could open new diagnostic and management options.

13 Sep 2010

Minister for Indigenous Health reinstated

As Prime Minister Julia Gillard announced her ministry this weekend, surprises came forth. Australian Medical Association and Aboriginal medical groups initially were dismayed when she decided to axe the Indigenous Health portfolio. Federal Labor MP Warren Snowdon was moved into Veterans' Affairs initially from where he was reinstated to his earlier position as Indigenous Health Minister. He assured that this reinstatement is not in response to the reaction from Indigenous and rural health groups.

13 Sep 2010

Victorian health system falters

In the latest annual report from Your Hospitals, that rates the efficiency of hospitals, Victorian hospitals have fared badly. It shows that more than 250,000 emergency department patients were not treated on time in the past year - an increase on four years ago.

13 Sep 2010

Laser acupuncture a plausible treatment for depression

Acupuncture produces significant changes in parts of the brain that regulate emotional states and is a biologically plausible treatment for depression and other neuropsychiatric disorders, Australian researchers have shown for the first time.

13 Sep 2010

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

AstraZeneca and UCL (University College London) today announced that they have entered into a collaboration to develop regenerative medicines for diabetic retinopathy (DR).

13 Sep 2010

LA community clinics facing budget squeeze; Milwaukee may target benefits of public employees; Seattle Times documents 236 deaths in adult homes

Los Angeles Times: "Stung by a budget stalemate that is costing Los Angeles County community clinics more than $330,000 a day in reimbursements, many clinic managers have been forced to take out loans and contemplate cuts to staff and services. Without the funds from Medi-Cal, the state insurance program for low-income patients, 41 clinics statewide have applied for loans from a fund created in response to the budget impasse.

13 Sep 2010

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

Kowa Company, Ltd. announced today that the results of a Phase II/III trial showed that high dose peretinoin (NIK-333) given daily for up to 96 weeks reduced the recurrence of hepatocellular carcinoma (HCC) after surgical resection or ablation in hepatitis C virus (HCV) positive patients when compared to placebo.

13 Sep 2010

Health care expected to help fuel job growth yet new nurses having difficulties finding jobs

Orlando Sentinel: "Thousands more health-care workers, from doctors to nurses to physical therapists, will be needed in the coming decade in Florida and across the country to treat the increasing number of older Americans — particularly the enormous baby boom generation. According to the U.S. Bureau of Labor Statistics, health care is expected to generate 3.2 million new jobs through 2018, more than any other industry and mainly because of the increasing number of elderly.

13 Sep 2010

Discovery shows how cells decide what to recycle, unlocking debilitating disease's secret

Our bodies recycle proteins, the fundamental building blocks that enable cell growth and development. Proteins are made up of a chain of amino acids, and scientists have known since the 1980s that first one in the chain determines the lifetime of a protein. McGill researchers have finally discovered how the cell identifies this first amino acid - and caught it on camera.

13 Sep 2010

Hearing scheduled this week for closely watched health law challenge in Florida

Lawmakers and others are closely watching a lawsuit brought in Florida by a pair of conservative Washington, D.C., lawyers that challenges the health reform law as bearing a possibility of what the future will bring for the overhaul. The Wall Street Journal reports that the suit, "filed in Florida by David Rivkin and Lee Casey, is one of a handful of challenges lodged against the law in recent months.

13 Sep 2010

HealthWyse, Cardiocom partner to integrate patient information into clinical software

HealthWyse, a leading provider of home health and hospice software and services, announced today that it has partnered with Cardiocom, a leader in home telehealth solutions, to seamlessly integrate patient information into HealthWyse's clinical software.

13 Sep 2010

Medical News

Arno Therapeutics closes private placement to advance cancer treatment

Study finds new therapeutic target for polycystic kidney disease

Ironwood, Forest Laboratories announce positive results for linaclotide Phase 3 clinical trials in IBS-C patients

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Arthritis Foundation, Takeda launch Gout Living educational campaign

Advantec announces partnership with Teladoc for telehealth consultations

Pharmacyclics reports $9.3 million increase in total revenue for 2010 fiscal year

Queensland health staff threaten to strike

Complementary medicine to save millions: Report

Myopia and Glaucoma genes identified

Minister for Indigenous Health reinstated

Victorian health system falters

Laser acupuncture a plausible treatment for depression

AstraZeneca, UCL collaborate to identify new therapeutic tools to modulate regenerative capacity of stem cells

LA community clinics facing budget squeeze; Milwaukee may target benefits of public employees; Seattle Times documents 236 deaths in adult homes

High dose peretinoin reduces recurrence of HCC after surgical resection or ablation in HCV positive patients

Health care expected to help fuel job growth yet new nurses having difficulties finding jobs

Discovery shows how cells decide what to recycle, unlocking debilitating disease's secret

Hearing scheduled this week for closely watched health law challenge in Florida

HealthWyse, Cardiocom partner to integrate patient information into clinical software

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News